Dr. Tenen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Medical Center
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-5561
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984- Brigham and Women's HospitalResidency, Internal Medicine, 1978 - 1981
- Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1977
Harvard Medical SchoolClass of 1975
Certifications & Licensure
CA State Medical License 1977 - Present
MA State Medical License 1976 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3145 citationsEGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to GefitinibSusumu Kobayashi, Titus J. Boggon, Tajhal Dayaram, Pasi A. Jänne, Olivier Kocher
The New England Journal of Medicine. 2005-02-24 - 62 citationsDynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors.Gillian May, Shamit Soneji, Alex J. Tipping, José Teles, Simon J. McGowan
Cell Stem Cell. 2013-12-05 - 233 citationsThe Kruppel-like factor KLF4 is a critical regulator of monocyte differentiationMark W. Feinberg, Akm Khyrul Wara, Zhuoxiao Cao, Maria A. Lebedeva, Frank Rosenbauer
The EMBO Journal. 2007-09-19
Press Mentions
Mutant p53 Drives Clonal Hematopoiesis Through Modulating Epigenetic PathwayDecember 11th, 2019
Grant Support
- Molecular Biology Of Myeloid DifferentiationNational Heart, Lung, And Blood Institute2012
- Oncogenesis And Myeloid Transcription Factors In AMLNational Cancer Institute2008–2012
- Hematopoietic Stem Cell CommitmentNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Targeting Leukemic Stem CellsNational Cancer Institute2008–2011
- Distinct Acute Myeloid Leukemia Subclasses With Cebpa MutationsNational Cancer Institute2007–2011
- Role Of C/Ebpalpha And MyelopoiesisNational Heart, Lung, And Blood Institute2001–2010
- Molecular Biology Of Human Myeloid DifferentiationNational Cancer Institute1986–2010
- FOXA2 And C/EBP Transcription Factors In The Pathogenesis And Treatment Of Lung CNational Cancer Institute2008–2009
- Molecular Biology Of Myeloid DifferentiationNational Cancer Institute2004–2008
- Interacting Factors In Hematopoiesis And LeukemiaNational Cancer Institute2003–2007
- Regulation Of The Human CD34 Stem Cell GeneNational Institute Of Diabetes And Digestive And Kidney Diseases1994–2007
- Transcription Factor Mutations And Human AMLNational Cancer Institute2000–2004
- Shared Resource For Transgenic Mouse Models Of CancerNational Cancer Institute1999–2003
- Oncogenesis And Myeloid Transcription In AMLNational Cancer Institute2002
- AAV Gene Therapy Of Stem Cells And MacrophagesNational Heart, Lung, And Blood Institute1999–2001
- Role Of ETS Factor PU.1 And C/Ebp-Alpha In MyelopoiesisNational Cancer Institute1997–2001
- ETS Protein Interactions In Hematopoiesis And LeukemiaNational Cancer Institute1997–2001
- C/EBP Alpha And MyelopoiesisNational Heart, Lung, And Blood Institute1996–2000
- New Vectors For Gene Expression In Hematopoietic CellsNational Heart, Lung, And Blood Institute1996–1999
- New Vectors For Gene Expression In Hematopoietic CellsNational Heart, Lung, And Blood Institute1996–1997
- Development Of Anti-Hiv Vectors In Monocytes/MacrophagesNational Institute Of Allergy And Infectious Diseases1990–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
